LMR Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-500
Closed -$260K 1315
2024
Q3
$260K Buy
+500
New +$267K ﹤0.01% 939
2024
Q2
Sell
-2,800
Closed -$1.45M 1155
2024
Q1
$1.45M Hold
2,800
0.01% 613
2023
Q4
$1.32M Hold
2,800
0.02% 533
2023
Q3
$1.22M Buy
+2,800
New +$1.27M 0.01% 456

Other funds holding ELV

LMR Partners's ELV Position: Q1 2026 in Review

LMR Partners reduced its Elevance Health (ELV) stake by 56% in Q1 2026, selling an estimated $3.29M and leaving 7,887 shares worth $2.31M. The position accounts for 0.01% of the portfolio, ranked #828.

LMR Partners first reported a position in ELV in Q2 2014 and has held it in 35 quarters since. The position peaked at $9.44M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • LMR Partners held 7,887 shares of Elevance Health worth $2.31M as of Q1 2026.
  • LMR Partners sold 10,000 Elevance Health shares in Q1 2026, an estimated $3.29M.
  • Elevance Health made up 0.01% of LMR Partners's portfolio in Q1 2026, its #828 holding.
  • LMR Partners first reported a position in Elevance Health in Q2 2014 and has held it in 35 quarters since.
  • LMR Partners's Elevance Health position peaked at $9.44M in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.